Bevaro 100 mg Injection
  1. Home
  2. Pharma Products
  3. Cadila Pharmaceutical Ltd
  4. Bevaro 100 mg Injection

Bevaro 100 mg Injection

Bevaro 100 mg Injection contains bevacizumab, a monoclonal antibody used in the treatment of several types of cancer. It is supplied as a 100 mg/4 mL injection and is administered by intravenous infusion under medical supervision. Bevacizumab blocks VEGF, helping limit the blood supply that supports tumor growth.

BUY NOW

Category

Bevaro 100 mg Injection is used with appropriate anticancer treatment for conditions such as metastatic colorectal cancer, non-small cell lung cancer, kidney cancer, cervical cancer, and selected ovarian cancers. Bevacizumab targets vascular endothelial growth factor, a protein involved in the formation of new blood vessels around tumors. Blocking this pathway can reduce the supply of oxygen and nutrients available to growing cancer cells. Treatment should be administered according to the prescribed oncology protocol with appropriate monitoring for infusion reactions, blood pressure changes, bleeding, and other adverse effects.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 100 mg
Concentration 100 mg/4 mL
Dosage Form Injection
Route of Administration Intravenous Infusion
Pack Size 1 Vial of 4 mL

Product Also Known As

Bevaro 100 mg Injection, Bevaro 100 Injection, Bevaro Bevacizumab Injection, Bevacizumab 100 mg Injection, Bevacizumab 100 mg/4 mL Injection, Bevacizumab Cancer Injection